✦ LIBER ✦

Striatal circuits, habits, and implications for obsessive–compulsive disorder

✍ Scribed by Burguière, Eric; Monteiro, Patricia; Mallet, Luc; Feng, Guoping; Graybiel, Ann M

Book ID: 126853073
Publisher: Elsevier Science
Year: 2015
Tongue: English
Weight: 406 KB
Volume: 30
Category: Article
ISSN: 0959-4388
DOI: 10.1016/j.conb.2014.08.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Obsessive-compulsive personality disorde

Obsessive-compulsive personality disorder co-occurring with obsessive-compulsive disorder: Conceptual and clinical implications

✍ Starcevic, V.; Berle, D.; Brakoulias, V.; Sammut, P.; Moses, K.; Milicevic, D.; 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 740 KB

Obsessive-compulsive disorder phenotypes

Obsessive-compulsive disorder phenotypes: implications for genetic studies

✍ Miguel, E C; Leckman, J F; Rauch, S; do Rosario-Campos, M C; Hounie, A G; Mercad 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 247 KB

Functional neuroimaging implications for

Functional neuroimaging implications for obsessive-compulsive disorder neurosurgery

✍ Baxter, L.; Saxena, S.; Brody, A.; Schwartz, J.; Ackermann, R. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 152 KB

S.09.03 The role of habit in obsessive-c

S.09.03 The role of habit in obsessive-compulsive disorders: implications for pharmacotherapy

✍ Fineberg, N.A.; Sahakian, B.J.; Chamberlain, S.R.; Gillan, C.M.; Apergis Schoute 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Neurosteroids modulate compulsive and pe

Neurosteroids modulate compulsive and persistent behavior in rodents: Implications for obsessive–compulsive disorder

✍ Umathe S.N.; Vaghasiya J.M.; Jain N.S.; Dixit P.V. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 343 KB

Pharmacotherapy for obsessive-compulsive

Pharmacotherapy for obsessive-compulsive disorder

✍ Darin D. Dougherty; Scott L. Rauch; Michael A. Jenike 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

## Abstract Pharmacotherapeutic options for obsessive‐compulsive disorder (OCD) have expanded over the past half‐century since medications were first found to be effective for the treatment of OCD. Currently, the serotonin reuptake inhibitors (SRIs) represent the first‐line pharmacotherapy for OCD.